OB/GYN News - HT product with drospirenone wins approval
November 1, 2005 -- A combination hormone therapy that contains drospirenone was approved in late September for treating moderate to severe vasomotor symptoms and...
Skin & Allergy News - Low-dose drospirenone in OC eases premenstrual symptoms
July 1, 2005 -- SAN FRANCISCO -- A new drospirenone-based OC awaiting approval by the Food and Drug Administration is effective in relieving premenstrual symptoms...
OB/GYN News - Combo HT curbs hot flashes, cuts blood pressure: drospirenone has antialdosterone effects
May 15, 2006 -- WASHINGTON -- The combination of drospirenone (a progestin with antialdosterone effects) and 17-[beta]-estradiol as hormone therapy for hypertensive...
American Family Physician - Ethinyl estradiol/drospirenone : a newer oral contraceptive
May 15, 2004 -- Synopsis: Ethinyl estradiol/drospirenone (Yasmin) is a monophasic oral contraceptive containing 30 mcg of ethinyl estradiol and 3 mg of a unique...
OB/GYN News - Investigational OC may decrease PMDD symptoms: regimen of 24 days of low-dose drospirenone tied to fewer symptoms during the pill-free interval
July 15, 2005 -- SAN FRANCISCO -- A new drospirenone-based OC awaiting approval by the Food and Drug Administration is effective in relieving premenstrual symptoms...
OB/GYN News - Drospirenone-ethinyl called good option for PCOS - Expert Opinion
June 15, 2002 -- VAIL. COLO. -- The oral contraceptive drospirenone-ethinyl estradiol is a particularly attractive option for treatment of polycystic ovary syndrome...
Market Wire - Watson Files FDA Application for Generic YASMIN(R)
April 21, 2008 -- Watson Pharmaceuticals, Inc. (NYSE: WPI), aleading specialty pharmaceutical company, today confirmed that it has filedan Abbreviated New Drug...
PR Newswire - Barr Announces Approval of Generic Yasmin
May 9, 2008 -- MONTVALE, N.J., May 9 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. today announced that its subsidiary, Barr Laboratories, Inc., has...
PR Newswire - Barr Announces Favorable Ruling in Yasmin® Patent Challenge
March 3, 2008 -- MONTVALE, N.J., March 3 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. today announced that the U.S. District Court for the District of New...
Dermatology Nursing - Bayer Healthcare and Intendis Inc. form alliance to promote YAZ
August 1, 2007 -- Bayer Healthcare and Intendis Inc. announced their intentions to join forces in promoting YAZ[R] (drospirenone/ehinyl estradiol) as not only an oral...
